Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of OliX Pharmaceuticals patents

List of OliX Pharmaceuticals patents

List of Uponor patents

List of Mossey Creek Technologies Inc. patents

List of Wenger Corporation patents

List of awards received by Dejan Lovren

List of AI urban planning companies

Patents where

Current Assignee

Name

is

OliX Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor	Patent 10125362 was granted and assigned to OliX Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10125362	November 13, 2018
	‌ US Patent 11591600 Long double-stranded RNA for RNA interference		OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	11591600	February 28, 2023
	‌ US Patent 10064801 RNA complexes that inhibit melanin production	Patent 10064801 was granted and assigned to OliX Pharmaceuticals on September, 2018 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10064801	September 4, 2018
	‌ US Patent 10947541 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1	Patent 10947541 was granted and assigned to OliX Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10947541	March 16, 2021
	‌ US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1	Patent 10358648 was granted and assigned to OliX Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10358648	July 23, 2019
	‌ US Patent 10829760 Nucleic acid molecules inducing RNA interference, and uses thereof		OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10829760	November 10, 2020
	‌ US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3	Patent 10059949 was granted and assigned to OliX Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10059949	August 28, 2018
	‌ US Patent 11040057 Pharmaceutical compositions and methods for potentiating gene silencing	Patent 11040057 was granted and assigned to OliX Pharmaceuticals on June, 2021 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	11040057	June 22, 2021
	‌ US Patent 10829761 Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor		OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10829761	November 10, 2020
	‌ US Patent 10883105 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor	Patent 10883105 was granted and assigned to OliX Pharmaceuticals on January, 2021 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10883105	January 5, 2021
	‌ US Patent 10590423 Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3	Patent 10590423 was granted and assigned to OliX Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10590423	March 17, 2020
	‌ US Patent 10519449 Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB	Patent 10519449 was granted and assigned to OliX Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10519449	December 31, 2019
	‌ US Patent 10512600 RNA complexes that inhibit melanin production	Patent 10512600 was granted and assigned to OliX Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10512600	December 24, 2019
	‌ US Patent 10301628 Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor	Patent 10301628 was granted and assigned to OliX Pharmaceuticals on May, 2019 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	10301628	May 28, 2019
	‌ US Patent 11118184 Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene	Patent 11118184 was granted and assigned to OliX Pharmaceuticals on September, 2021 by the United States Patent and Trademark Office.	OliX Pharmaceuticals	OliX Pharmaceuticals		United States Patent and Trademark Office	11118184	September 14, 2021

15 results

0 selected

15 results

0 selected